Literature DB >> 2102680

Radionuclide esophageal transit study in detection of esophageal motor dysfunction: comparison with motility studies (manometry)

R Taillefer1, M Jadliwalla, E Pellerin, E Lafontaine, A Duranceau.   

Abstract

Radionuclide esophageal transit study (RETS) has been developed to assess motor function of the esophagus. The purpose of this study was to compare RETS to esophageal motility studies (EMS) in detection of motility disorders. A total of 109 consecutive patients without previous history of surgery on the esophagus underwent both RETS and EMS within one month of each other. Final diagnosis was divided into three categories: I--primary esophageal motor disorders (n = 39); II--reflux disease (n = 48); and III--non-cardiac chest pain and/or dysphagia (n = 22). Using EMS as the standard, the results of RETS were as follows: sensitivity for detection of motor dysfunction was 97%, 92%, and 77% for Groups I, II, and III, respectively, while specificity was 91% for Group II and 100% for Group III. Global sensitivity was 92% and specificity was 88%. No clinically significant motor disorders were missed by RETS. In conclusion, RETS is a useful noninvasive test for the screening of patients with symptoms thought to be of esophageal origin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2102680

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  9 in total

1.  Radionuclide esophageal transit time in patients of suspected esophageal motility disorders.

Authors:  S H Khan; T A Rather; B ul Rehman; G M Gulzar; T A Mir; S A Zargar
Journal:  Indian J Gastroenterol       Date:  2009 Mar-Apr

2.  The clinical utility of provocative radionuclide oesophageal transit in the evaluation of non-cardiac chest pain.

Authors:  R S Elloway; M P Jacobs; M F Nathan; J C Mantil
Journal:  Eur J Nucl Med       Date:  1992

3.  The use of esophageal transit and gastric emptying studies in the evaluation of patients undergoing laparoscopic fundoplication.

Authors:  Matthew J Schuchert; Brian L Pettiford; Ghulam Abbas; Alicia Oostdyk; James R Landreneau; Arman Kilic; Joshua P Landreneau; James D Luketich; Rodney J Landreneau
Journal:  Surg Endosc       Date:  2010-05-19       Impact factor: 4.584

4.  Clinical applications of oro-pharyngo-oesophageal scintigraphy in the study of dysphagia.

Authors:  B Fattori; M Grosso; F Ursino; F Matteucci; V Mancini; E Rizza; V Mattone; G Mariani; A Nacci
Journal:  Acta Otorhinolaryngol Ital       Date:  2007-08       Impact factor: 2.124

5.  Esophageal dysfunction in patients with atypical chest pain investigated with esophageal scintigraphy and myocardial perfusion imaging: an outcome study.

Authors:  Douglas Howarth; Geoffrey Oldfield; John Booker; Phillip Tan
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

6.  Optimal evaluation of patients with nonobstructive esophageal dysphagia. Manometry, scintigraphy, or videoesophagography?

Authors:  H P Parkman; A H Maurer; D F Caroline; D L Miller; B Krevsky; R S Fisher
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

7.  In-house-Prepared Semisolid Bolus for Esophageal Transit Scintigraphy in Normal Volunteers and its Comparison with Liquid Bolus.

Authors:  Ashwani Sood; Sanjay Gambhir; Deepa Singh; K Utham Kumar; Ashwin Singh Parihar; Subhash Kheruka; Veeresh Dube; Satyawati Deswal
Journal:  Indian J Nucl Med       Date:  2020-03-12

8.  Scintigraphic evaluation of oesophageal transit during radiotherapy to the mediastinum.

Authors:  Giuseppe Sasso; Pierfrancesco Rambaldi; Francesco S Sasso; Vincenzo Cuccurullo; Paola Murino; Paolo Puntieri; Hugo R Marsiglia; Luigi Mansi
Journal:  BMC Gastroenterol       Date:  2008-11-05       Impact factor: 3.067

9.  Radionuclide Esophageal Transit Scintigraphy in Primary Hypothyroidism.

Authors:  Shoukat H Khan; Vijay P Madhu; Tanveer A Rather; Bashir A Laway
Journal:  J Neurogastroenterol Motil       Date:  2017-01-30       Impact factor: 4.924

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.